Site Attachment Inhibition: Research Note

Abstract

One issue with stem cell therapy immunization is that it requires the embryo to undergo stem cell therapy and not all pregnancies are identified this early.

The solution to this has already been discussed. Stem cell therapy could be carried out at spermatogenesis and oogenesis. The genes targeted that which correspond to embryonic CCR5-32, taking into account association versus causation.

Whilst this may seem burdensome, it depends how keen society is to eradicate HIV.

Ethics approval has been granted for embryonic stem cell therapy above but not yet for oogenesis and spermatogenesis.